Distributed Agent-Based Simulation with Repast4Py
This tutorial presents Repast4Py, a Python-based agent-based modeling (ABM) toolkit, and the newest member of the Repast Suite of agent-based modeling toolkits. The tutorial presents key Repast4Py components and how they are combined to create distributed simulations of different types,…
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts
Carceral officials often cite diversion of medication for opioid use disorder (MOUD) (e.g., buprenorphine) as a reason for not offering MOUD treatment in jails and prisons with little understanding of patient perspectives. We aimed to understand patient perceptions of medication…
Ending the HIV Epidemic for Persons Who Use Drugs: The Practical Challenges of Meeting People Where They Are
The four-pillar evidence-based EHE plan’s primary goal is to reduce the number of new HIV infections by 90% by 2030 and includes recommendations to (1) test everyone for HIV; (2) treat those who test positive with RAPID antiretrovirals and ensure…
Endorsement of COVID-19 misinformation among criminal-legal involved individuals in the US
Criminal legal system involvement (CLI) is a critical social determinant of health that lies at the intersection of multiple sources of health disparities. The COVID-19 pandemic exacerbates many of these disparities, and specific vulnerabilities faced by the CLI population. This…
Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails
This study used a predictive model to examine the potential impact of screening and treatment for opioid use disorder (OUD) within prisons and jails on opioid-related mortality after release. The model results indicate that widespread uptake of screening and treatment…
Ethical Approaches to Vaccine Allocation and Administration in Carceral Settings, With a Focus on Youth
We examine the ethical issues that arise in the health care of minors in carceral settings and identify an ethical model that could be used when considering how to the allocate COVID-19 vaccines.